Proprietary Neural Exosome Platform for Neurological Diseases

We are excited to announce our next Mar 22nd Knowledge Sharing MSQ CEO Webinar Series as we invite our special guest speaker CEO Stephen From and Steven Stice, Co-Founder, and Chief Scientific Officer of Aruna Bio who will present on: “Proprietary Neural Exosome Platform for Neurological Diseases”.  

They will both share their insights on their clinical pipeline's value proposition and differentiation, upcoming catalysts/ milestones, and potential strategic partnering/ investment opportunities.

By developing its proprietary neural exosome platform, Aruna Bio has succeeded in gaining access across the blood-brain barrier. Their therapeutic neural cell-derived exosome, AB126, demonstrates multiple modes of action reducing neuro-inflammation, promoting neuro-protection, and stimulating neuro-regeneration. This makes AB126 ideal for the treatment of acute neuro-conditions and chronic neurodegenerative diseases which could transform the lives of millions of people around the world.  

Co-host: MSQ Ventures and BioAroundWorld 

Guest Speaker: Stephen From, CEO, Aruna Bio  

                         Steven Stice, Co-Founder, and Chief Scientific Officer 

Moderator: Marc Estigarribia, Managing Director, MSQ Ventures  

Date: Wednesday, March 22nd, 2023 

Time: 9pm – 10pm BJT 

9am – 10am ET 

Webinar Format: 

• Webinar is 1 hour in length including: 

• 10-15 min MSQ intro w/ CEO  

• 30-minute company presentation  

• 10–15-minute Q&A 

Register Here: https://lnkd.in/eEPMBg3h 

* After the webinar, attendees will have an opportunity to set up a 1-1 session with the guest speaker post event via MSQ